Researchers are developing mRNA-based cancer vaccines designed to train the immune system to recognize and attack cancer cells more effectively. • These vaccines use mRNA technology to target tumor-specific antigens. • They are often personalized, created using genetic information from a patient’s tumor. • Early clinical trials show strong and durable immune responses in some patients. • In certain cases, patients have remained cancer-free for multiple years during follow-up. • The vaccines are